Results 81 to 90 of about 775,328 (297)

Minimal residual disease detection in lymphoma: methods, procedures and clinical significance

Frontiers in Immunology
Lymphoma is a highly heterogeneous lymphohematopoietic tumor. As our understanding of the biological and pathological characteristics of lymphoma improves, we are identifying an increasing number of lymphoma subtypes.
Sijun Zhang, Xiangyu Wang, Zhenzhen Yang, Mengjie Ding, Mingzhi Zhang, Ken H. Young, Xudong Zhang   +6 more
doaj   +1 more source

Sustained minimal residual disease in myeloma [PDF]

, 2022
Giada Bianchi
openalex   +1 more source

Cisplatin-based chemotherapy of testicular cancer - Two decades after a major breakthrough [PDF]

, 2000
Two decades ago the introduction of cisplatin-based combination chemotherapy has dramatically improved the prognosis of patients with metastatic testicular cancer, At present 3 cycles of cisplatin, etoposide and bleomycin are considered as standard ...
Gerl, Arthur
core   +1 more source

Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models. [PDF]

, 2015
Malignant melanoma requires precise resection in order to avoid metastatic recurrence. We report here that the telomerase-dependent, green fluorescent protein (GFP)-containing adenovirus OBP-401 could label malignant melanoma with GFP in situ in ...
Bouvet, Michael, Fujiwara, Toshiyoshi, Hoffman, Robert M, Kagawa, Shunsuke, Kishimoto, Hiroyuki, Takehara, Kiyoto, Urata, Yasuo, Yano, Shuya   +7 more
core   +1 more source

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Blood Cancer Discovery, 2021
NGS-MRD >0 is highly predictive of relapse after tisagenlecleucel therapy for ALL. Serial monitoring of NGS-MRD and B-cell aplasia identifies high-risk patients with sufficient time for interventions to prevent relapse.
M. Pulsipher, Xia Han, S. Maude, T. Laetsch, M. Qayed, S. Rives, M. Boyer, H. Hiramatsu, G. Yanik, T. Driscoll, G. D. Myers, P. Bader, A. Baruchel, J. Buechner, H. Stefanski, C. Kalfoglou, K. Nguyen, Edward R. Waldron, Karen Thudium Mueller, Harald J. Maier, G. Kari, S. Grupp   +21 more
semanticscholar   +1 more source

The potential for liquid biopsies in the precision medical treatment of breast cancer. [PDF]

, 2016
Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology.
Barrak, Dany K, Elhodaky, Mostafa, Forte, Victoria A, Lang, Julie E, Snow, Anson, Tung, Lily   +5 more
core   +1 more source

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

Cancers, 2021
Simple Summary Acute lymphoblastic leukemia minimal residual disease (MRD) refers to the presence of residual leukemia cells following the achievement of complete remission, but below the limit of detection using conventional morphologic assessment.
G. P. Contreras Yametti, Talia H Ostrow, S. Jasinski, E. Raetz, W. Carroll, Nikki A. Evensen   +5 more
semanticscholar   +1 more source

Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia

Advanced Medical Journal
Background and ObjectiveThe detection of minimal residual disease at the end of initial therapy in Acute Lymphoblastic Leukemia to assess risk stratification is gaining clinical significance.
Fatima Hameed Ahmad, Adnan Anwer Al-Doski   +1 more
doaj   +1 more source

Advances in the assessment of minimal residual disease in mantle cell lymphoma

Journal of Hematology & Oncology, 2020
The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse large B cell lymphoma.
Dayoung Jung, Preetesh Jain, Yixin Yao, Michael Wang   +3 more
doaj   +1 more source

An evaluation of enteral nutrition practices and nutritional provision in children during the entire length of stay in critical care [PDF]

, 2014
<b>Background</b> Provision of optimal nutrition in children in critical care is often challenging. This study evaluated exclusive enteral nutrition (EN) provision practices and explored predictors of energy intake and delay of EN ...
A Slater, AF Rousseau, C Lambe, David Young, DO Health, EJ Rogers, Emma Gentles, GC Briassoulis, GS Doig, GS Doig, H Woien, Hani A Alfheeaid, IM Mitchell, J Hulst, Jackie Mara, JL Vazquez Martinez, JM Hulst, JM Hulst, Konstantinos Gerasimidis, Krystalia Diamantidi, LF Lima, MA Holliday, Mark Davidson, MM Pollack, Neil Spenceley, NM de, R Meyer, RM Taylor, SB de Oliveira Iglesias, T Petrillo-Albarano, TA Mikhailov, TJ Cole, WN Schofield   +32 more
core   +3 more sources